Dublin, May 16, 2022 /PRNewswire/—— “Global Contract Development and Manufacturing Organizations (CDMO) Market: Insights and Forecasts with Potential COVID-19 Impact (2022-2026)” report added to ResearchAndMarkets.com’s supply.
The global CDMO market is expected to reach $246.6 billion CAGR of 9.31% in 2026, period 2022-2026
Factors such as increasing per capita disposable income, increasing global healthcare spending, increasing aging population, increasing R&D spending, increasing number of new drugs, increasing investments and strategic collaborations, and growing demand for pharmaceutical products are expected to drive the market.
However, the growth of the industry will be challenged by strict government regulations. Some notable trends include growing demand for efficient API manufacturing services, growing demand for quality design services, growth in the field of oncology, growing demand for process development CDMO services, and lengthy and expensive drug development processes.
In terms of services, the global API drug market holds the highest market share and is expected to grow in the future owing to the increasing number of biologics APIs in pipeline stage and increasing adoption of multiple therapeutics. In terms of products, due to the surge in global drug R&D activities, small molecule drugs occupy a major market share.
Company profiles of leading players (Catalent, Inc., Recipharm AB, Evotec SE, Lonza Group AG, Biomerieux SA and Thermo Fisher Scientific Inc.) are also detailed
Key topics covered:
1. Introduction
1. CDMO
1.2 CDMO Services
1.3 Advantages of CDMO
2. Impact of COVID-19
2.1 The rise of clinical trials
3. Global CDMO Market Analysis
3.1 Global CDMO Market by Value
3.2 Global CDMO Market Value Forecast
3.3 Global CDMO Market by Service
3.3.1 Global API/API Market by Value
3.3.2 Global API/API Market Value Forecast
3.3.3 Global Pharmaceutical Manufacturing Market by Value
3.3.4 Global Pharmaceutical Manufacturing Market Value Forecast
3.3.5 Global Packaging Market Value
3.3.6 Global Packaging Market Value Forecast
3.4 Global CDMO Market by Product
3.4.1 Global Biologics CDMO Market by Value
3.4.2 Global Biological Products CDMO Market Value Forecast
3.4.3 Global Small Molecule CDMO Market Value
3.4.4 Global Small Molecule CDMO Market Value Forecast
3.5 Global CDMO Market by Regions
4. Regional CDMO Market Analysis
4.1 North America
4.1.1 North America CDMO Market by Value
4.1.2 North America CDMO Market Value Forecast
4.2 Europe
4.2.1 Europe CDMO Market by Value
4.2.2 European CDMO Market Value Forecast
4.3 Asia-Pacific
4.3.1 Asia Pacific CDMO Market by Value
4.3.2 Asia Pacific CDMO Market Value Forecast
4.4 Latin America
4.4.1 Latin America CDMO Market by Value
4.4.2 Latin America CDMO Market Value Forecast
4.5 middle East & Africa
4.5.1 middle East & Value of African CDMO Market
4.5.2 middle East and Africa CDMO market value forecast
5. Market dynamics
5.1 Growth drivers
5.1.1 Increase per capita disposable income
5.1.2 Increasing global healthcare spending
5.1.3 The aging of the population is increasing
5.1.4 Increase R&D spending
5.1.5 The increasing number of new drugs
5.1.6 Increase in investment and strategic cooperation
5.1.7 Growth in Demand for Pharmaceutical Products
5.2 Key Trends and Developments
5.2.1 Increasing Demand for Efficient API Manufacturing Services
5.2.2 Growing demand for quality in design services
5.2.3 Growth in Oncology Field
5.2.4 Growing Demand for Process Development CDMO Services
5.2.5 Lengthy and expensive drug development process
5.3 Challenges
5.3.1 Strict government regulations
6. Company Profile
For more information on this report, please visit https://www.researchandmarkets.com/r/4e2v9h
Media Contact:
Research and Marketing
Laura WoodSenior Manager
[email protected]
EST Office Hours Call +1-917-300-0470
US/Canada Toll Free +1-800-526-8630
GMT Office Hours Call +353-1-416-8900
US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716
SOURCE RESEARCH AND MARKET